Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: An effective salvage therapy option for acute myeloid leukemia at first relapse
Version 2 2024-06-13, 15:00
Version 1 2022-10-31, 01:27
journal contribution
posted on 2024-06-13, 15:00 authored by CY Fong, G Grigoriadis, J Hocking, J Coutsouvelis, J Muirhead, P Campbell, E Paul, P Walker, S Avery, S Patil, A Spencer, A Schwarer, A WeiFludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: An effective salvage therapy option for acute myeloid leukemia at first relapse
History
Journal
Leukemia and LymphomaVolume
54Pagination
336-341Location
United StatesISSN
1042-8194eISSN
1029-2403Language
enPublication classification
C1.1 Refereed article in a scholarly journalIssue
2Publisher
Informa UK LimitedUsage metrics
Keywords
AdolescentAdultAgedAmsacrineAntineoplastic Combined Chemotherapy ProtocolsCytarabineFemaleGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell TransplantationHumansLeukemia, Myeloid, AcuteMaleMiddle AgedPrognosisRecurrenceSalvage TherapyTransplantation, HomologousTreatment OutcomeVidarabineYoung Adult
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC